|
STATA Corporation
frequentist network meta analysis nma ![]() Frequentist Network Meta Analysis Nma, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/frequentist+network+meta+analysis+nma/STATA+14%2E0/pmc13043226-51-3-8 Average 99 stars, based on 1 article reviews
frequentist network meta analysis nma - by Bioz Stars,
2026-09
99/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Cardiovascular Pharmacology
Article Title: Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis
doi: 10.1097/FJC.0000000000001785
Figure Lengend Snippet: Network diagram of comparative network meta-analysis for CETP inhibitor-based regimens. Each node represents a treatment, with size proportional to the number of included studies. Lines indicate direct comparisons between treatments. CETP, cholesteryl ester transfer protein.
Article Snippet: We conducted a
Techniques:
Journal: Journal of Cardiovascular Pharmacology
Article Title: Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis
doi: 10.1097/FJC.0000000000001785
Figure Lengend Snippet: Network meta-analysis results for ApoAI and ApoB. A and C show MDs with 95% confidence intervals; positive values indicate higher ApoAI or lower ApoB. B and D display cumulative ranking probabilities (SUCRA). ApoAI, apolipoprotein A-I; ApoB, apolipoprotein B.
Article Snippet: We conducted a
Techniques: